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background: Familial hypercholesterolemia (FH) is a genetic disorder that causes markedly elevated low-density lipoprotein (LDL) levels resulting 
in premature cardiovascular (CV) disease and death. There is limited data on whether providers recognize and appropriately treat FH patients in an 
ambulatory, real world setting.
methods: The electronic health records of all patients seen at Allina Health locations from 2009 to 2012 were reviewed to identify probable FH 
patients. An 80% probabilistic model was used with the following criteria: age <20 and LDL >190 mg/dL, age 20-29 and LDL >220 mg/dL, or age 
≥30 and LDL >250 mg/dL. Baseline demographics, statin use, National Cholesterol Education Program (NCEP) LDL treatment goals, follow up with a 
CV specialist, and formal diagnoses were recorded. 
results: In an ambulatory population of 391,166 patients, the prevalence of FH was 0.21% (n=841). Individuals with probable FH were 
predominantly white (91.4%) with a mean age of 53.3 ± 15.8 years and 39.0% were male. While 64.8% were on statin medications, 25.8% were 
not currently on a statin and were not reported to be statin intolerant and only 24.4% had achieved their NCEP LDL goal. Although 84.9% were 
diagnosed with a lipid disorder, only 4.3% were diagnosed with FH and only 31% had seen a CV specialist.
conclusions: In a large ambulatory population, provider recognition of FH is extremely low, one third are not on statin treatment and did not 
achieve NCEP LDL goal. Physician education of this high risk condition is needed.
